Co-/spl gamma/-Fe/sub 2/O/sub 3/
Preparation, characterization, and cytotoxicity of CPT/Fe<sub>2</sub>O<sub>3</sub>-embedded PLGA ultrafine composite fibers: a synergistic approach to develop promising anticancer material
... CPT/Fe 2 O 3 -PLGA blend system was determined in buffer solution with respect to the morphological changes of the fibrous ...CPT/Fe 2 O 3 -PLGA was observed at 355 ...
12
In vitro and in vivo targeting imaging of pancreatic cancer using a Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoprobe modified with anti-mesothelin antibody
... contain Fe, O, C, N, and Si, so the result shows Si and antibodies are coated on the ...nanoparticle. Fe 3 O 4 and SPIONs are most com- monly used for preparation of multifunctional ...
13
Immobilized transferrin Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery
... onto Fe 3 O 4 @SiO 2 nanoparticles with high doxorubicin (DOX) loading (TfDMP), for dual targeting of cancer, by chemically coupling both Tf and DOX with dual-function magnetic nanoparticles ...
9
Biological responses to core–shell-structured Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-NH<sub>2</sub> nanoparticles in rats by a nuclear magnetic resonance-based metabonomic strategy
... neopterin; o-hPa, ortho-hydroxyphenylacetate; Pa, picolinate; Pag, phenylacetylglycine; Pan, pantothenate; PaP, adenosine 3′,5′-diphosphate; Pc, phosphocholine; Phe, phenylalanine; p-hPa, ...
16
Polyetherimide-grafted Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging
... 60%. Fe 3 O 4 @SiO 2 /PEI, Fe 3 O 4 @SiO 2 / PEI/Sc shRNA, or Fe 3 O 4 @SiO 2 /PEI/VEGF shRNA was incubated with the cells in serum-free ...
13
<p>Green Synthesis of Zeolite/Fe<sub>2</sub>O<sub>3</sub> Nanocomposites: Toxicity & Cell Proliferation Assays and Application as a Smart Iron Nanofertilizer</p>
... 37°C) before being seeded into the wells of 96-well plates at a concentration of 5000 cells/well. HDF and HMM cells were maintained using fi ltered (bottle-top vacuum fi lter systems, 0.22 μ m pore size; Corning Inc.) ...
16
Biosafety evaluation of Janus Fe<sub>3</sub>O<sub>4</sub>-TiO<sub>2</sub> nanoparticles in Sprague Dawley rats after intravenous injection
... and Fe) was detected by inductively coupled plasma (ICP) mass spectrometry (MS; Nexion 300D; PerkinElmer ...caspase 3, Bcl2, Bax, p50, p53, Nrf2, Akt, and GAPDH were obtained from Cell Signaling Technology ...
15
Vancomycin-modified Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>@Ag microflowers as effective antimicrobial agents
... AgNO 3 and butylamine at a molar ratio of ...AgNO 3 and butylamine were added to the Fe 3 O 4 @SiO 2 ethanol solution, abundant and small Ag seeds were deposited uniformly on the ...
18
Co-encapsulation of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery
... The authors aimed to develop a MNP drug delivery system for intratumoral administration. A single emulsion evaporation method with magnetic Fe 3 O 4 cores and a shell of biocompatible polymeric PLGA ...
12
Effect of interaction of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> and artesunate on apoptosis of K562 cells
... purchased: 3-(4, 5- dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) (Ameresco, Solon, OH); Z-VAD-FMK (Beyotime Biotechnology); RPMI 1640 medium and fetal calf serum (GIBCO, USA); artesunate ...
8
Biocompatibility of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and their cytotoxic effect on MCF-7 cells
... Elemental analysis was performed using scanning electron microscopy-energy dispersive x-ray spectroscopy (SEM-EDS, EDAX 9100; EDAX International, Prairie View, IL). X-ray diffraction data were collected using an XD-D1 ...
10
Synthesis of composite magnetic nanoparticles Fe<sub>3</sub>O<sub>4</sub> with alendronate for osteoporosis treatment
... (Sigma-Aldrich Co.), ascorbic acid (C 6 H 8 O 6 ; Sigma-Aldrich ...(NaHCO 3 ; Sigma-Aldrich ...[KH 2 PO 4 ; Sigma-Aldrich ...Sigma-Aldrich Co.], sodium phosphate dibasic [Na 2 ...
12
Magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and chemotherapy agents interact synergistically to induce apoptosis in lymphoma cells
... Phamaceutical Co, Zhejiang, China), dexamethasone (Xianju Pharmaceutical Co, Zhejiang, China), MTT (Sigma-Aldrich Co, ...MNP-Fe 3 O 4 obtained from the State Key Laboratory of ...
6
Preparation and in vitro evaluation of doxorubicin-loaded Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles modified with biocompatible copolymers
... the Fe 3 O 4 -PLGA-PEG nanoparticles was also pH-dependent and enhanced at pH ...the Fe 3 O 4 -PLGA-PEG nanoparticles by a diffusion mechanism in ...
16
Fe<sub>3</sub>O<sub>4</sub>/Au magnetic nanoparticle amplification strategies for ultrasensitive electrochemical immunoassay of alfa-fetoprotein
... Cyclic voltammetry measurements were performed using an electrochemical analyzer CHI 660 (Shanghai Chenhua Instrumental Corp, China) connected to a personal com- puter. A three-compartment electrochemical cell contained ...
11
The effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> on immune function in normal ICR mice
... suspension was placed in a 96-well microtiter plate in 200 µ L aliquots, and cultured in the presence or absence of T-cell mitogen (concanavalin A [ConA], Sigma, USA) (5 µ g/mL). Meanwhile the wells receiving complete ...
7
Synergistic effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> with gambogic acid on apoptosis of K562 leukemia cells
... MNPs-Fe 3 O 4 (State Key Lab of Bioelectronics, Nanjing, China) were well distributed in RPMI 1640 medium containing 10% (v/v) heat-inactivated new-born calf serum (Sijiqing, Hangzhou, China) by ...
9
The effects of magnetite (Fe<sub>3</sub>O<sub>4</sub>) nanoparticles on electroporation-induced inward currents in pituitary tumor (GH<sub>3</sub>) cells and in RAW 264.7 macrophages
... chemical co-precipitation. The aqueous solutions containing 2 M Fe(II) and 1 M Fe(III) were prepared by dissolving FeCl 2 and FeCl 3 , ...produce Fe 3 O 4 ...
10
Fe<sub>3</sub>O<sub>4</sub>-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis
... developed Fe 3 O 4 -based poly(lactic-co- glycolic acid) (PLGA) nanoparticles (NPs) surface-modified with a cyclic Arg-Gly-Asp (cRGD) peptide as an MR contrast agent for the detection of ...
14
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>/DNR magnetic nanoparticles in the treatment of hematologic malignancies
... Reagent Co, Ltd (Shanghai, ...Products Co Ltd (Shanghai, ...Medicine Co Ltd., Lianyungang, China) methanol (Sinopharm Chemical Reagent Co Ltd, Shanghai, China), Giemsa staining solution ...
6